7-102457519-C-G
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_017621.4(ALKBH4):āc.784G>Cā(p.Glu262Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000144 in 1,612,960 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_017621.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ALKBH4 | ENST00000292566.4 | c.784G>C | p.Glu262Gln | missense_variant | 3/3 | 1 | NM_017621.4 | ENSP00000292566.3 | ||
ALKBH4 | ENST00000490528.1 | n.*564G>C | non_coding_transcript_exon_variant | 3/3 | 2 | ENSP00000420362.1 | ||||
ALKBH4 | ENST00000490528.1 | n.*564G>C | 3_prime_UTR_variant | 3/3 | 2 | ENSP00000420362.1 |
Frequencies
GnomAD3 genomes AF: 0.000138 AC: 21AN: 152218Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000209 AC: 52AN: 248310Hom.: 0 AF XY: 0.000185 AC XY: 25AN XY: 134818
GnomAD4 exome AF: 0.000145 AC: 212AN: 1460624Hom.: 2 Cov.: 30 AF XY: 0.000151 AC XY: 110AN XY: 726654
GnomAD4 genome AF: 0.000138 AC: 21AN: 152336Hom.: 0 Cov.: 32 AF XY: 0.0000537 AC XY: 4AN XY: 74486
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 25, 2022 | The c.784G>C (p.E262Q) alteration is located in exon 3 (coding exon 3) of the ALKBH4 gene. This alteration results from a G to C substitution at nucleotide position 784, causing the glutamic acid (E) at amino acid position 262 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at